Product Images Divalproex Sodium

This is a medication label for Divalproex Sodium DR Tablets USP 500 mg, with a National Drug Code (NDC) of 0615-8328-30. The tablets are to be stored between 20-25°C (68°-77°F) and dispensed in a tight, light-resistant container. The tablets should be swallowed whole and not crushed or chewed. The label provides information on the quantity, lot number, and expiration date of the tablets. It also provides a manufacturing code indicating that the medication was manufactured by Upsher-Smith and repackaged by Vangard Labs.*

The text represents a table that shows percentage values for two studies, Study 1 and Study 2, which evaluate a condition using two different scales, YMRS and MRS. The values range from 0% to 70%, and each study has four values presented in pairs using abbreviations: PBO and DVPX. There is no further context or explanation provided.*

This text appears to be a table illustrating results from a study of either Divalproex sodium or a placebo treatment. The table includes a column of percentages labeled "% Reduction in CPS Rate" ranging from -50% to 100% and a row labeled "Improvement" with columns labeled "Divalproex sodium" and "Placebo". There is also a row labeled "No Change" and "~— Worsening". It is not clear what the study was measuring or what the significance of the percentages are.*

This text is showing a chart or graph that displays the percentage reduction in CPS rate for high dose and low dose, and the corresponding percentage of patients that experienced improvement, no change, or worsening. No further context or details are available.*

The text seems to be describing two clinical studies evaluating the effects of a drug called Divalproes Sodium and its placebo. However, the scanning has resulted in incorrect spellings of the drug name, making it difficult to infer any specific details about the studies.*

This is a package of Divalproex Sodium DR Tabs USP 125mg with LOT 8326-EXP information on it. It is manufactured by Upsher-Smith and was packaged by Vangard. The package has various labels indicating different LOT numbers and expiration dates. The instructions on the package recommend storing the drug at a temperature range of 20°- 25°C (68°- 77° F) and the patient should swallow the tabs whole and not chew or crush them. This package is for institutional use only.*

This is a package of Divalproex Sodium DR Tabs, USP 250 mg. The package was manufactured by Upsher-Smith and packaged by Vangard. The tablets are for Rx-only use and must be dispensed in a light-resistant container. The package insert or label should be consulted for dosage information. The package should be stored at 20°C-25°C (68°F-77°F) or under controlled room temperature. Swallow the tablet whole and do not crush or chew the delayed-release tab. The trademark alongside the overall configuration of the package belongs to Omnicare, Inc.*

This appears to be a list of medication labels, including the drug name, dosage, lot number, expiration date, and manufacturer information for Divalproex Sodium DR Tab USP 250mg. It also includes a Food and Drug Administration National Drug Code.*

This is a package containing Divalproex Sodium DR Tabs USP 500mg manufactured by Upsher-Smith. The lot number is 8328.AA-39400 with an expiration date of January 30. There are directions for use and storage, along with warnings to not crush or chew. The package contains multiple tablets with different lot and expiration numbers. The text contains several errors and inconsistencies, indicating poor quality .*